Psomagen (XKRX:950200) Total Liabilities: ₩21,162 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:950200 Psomagen Inc XKRX:950200
72 GF Score
Price ₩3,230.00
GF Value ₩5,268.78
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Psomagen Total Liabilities?

Psomagen XKRX:950200 -1.22% 72 Total Liabilities is ₩21,162 Mil as of Jun. 2026. GuruFocus rates XKRX:950200 with a GF Score™ of 72/100 and a GF Value™ of ₩5,268.78 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Psomagen's Total Liabilities for the quarter that ended in Jun. 2026 was ₩21,162 Mil.

Psomagen's quarterly Total Liabilities increased from Dec. 2025 (₩24,067.38 Mil) to Mar. 2026 (₩27,037.74 Mil) but then declined from Mar. 2026 (₩27,037.74 Mil) to Jun. 2026 (₩21,161.54 Mil).

Psomagen's annual Total Liabilities increased from Dec. 2023 (₩12,350.11 Mil) to Dec. 2024 (₩25,149.52 Mil) but then declined from Dec. 2024 (₩25,149.52 Mil) to Dec. 2025 (₩24,067.38 Mil).

Psomagen Total Liabilities Historical Data

* Premium members only.

The historical data trend for Psomagen's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psomagen Total Liabilities Chart

Psomagen Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 15,393.36 13,519.99 12,350.11 25,149.52 24,067.38

Psomagen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,867.66 28,131.79 24,067.38 27,037.74 21,161.54
XKRX:950200
72GF Score
Psomagen Inc XKRX:950200
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Psomagen Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Psomagen's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=15491.929+(8487.357+88.094000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=24,067

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=49782.121-25714.741
=24,067

Psomagen's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12581.355+(8170.779+409.401
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=21,162

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=53114.983-31953.448
=21,162

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₩21,162 Mil mean?
Psomagen (XKRX:950200) has a Total Liabilities of ₩21,162 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Psomagen and its competitors.
Is Psomagen's Total Liabilities too high?
Psomagen's current Total Liabilities is ₩21,162 Mil. Overall, Psomagen has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Psomagen's Total Liabilities compare to TMO and DHR?
Psomagen's Total Liabilities of ₩21,162 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Psomagen and its competitors. Psomagen's current Total Liabilities is ₩21,162 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psomagen stock overvalued right now?
Based on GuruFocus' analysis, Psomagen (XKRX:950200) is currently considered Significantly Undervalued. The stock's GF Value™ is ₩5,268.78, compared to a current price of ₩3,230.00 — trading 38.7% below its estimated fair value. The current Total Liabilities is ₩21,162 Mil. Psomagen's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Psomagen (XKRX:950200), the current Total Liabilities is ₩21,162 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Psomagen (XKRX:950200) Overvalued in 2026?

Based on GuruFocus' analysis, Psomagen stock appears to be undervalued. The current stock price of ₩3,230.00 is trading 38.7% below its estimated GF Value™ of ₩5,268.78. GuruFocus considers Psomagen to be Significantly Undervalued.

Key valuation signals for XKRX:950200:

  • Total Liabilities: ₩21,162 Mil
  • GF Value™: ₩5,268.78 vs. price of ₩3,230.00 (38.7% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the XKRX:950200 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Psomagen Business Description

Address 1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850
Psomagen Inc provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.
72GF Score

Get the complete analysis for XKRX:950200

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,230.00
Price
₩5,268.78
GF Value